Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Asia News Asia: Top News and Analysis Eli Lilly and Co
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Europe News Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health care industry Eli Lilly and Co Healthy Returns
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Pharmaceuticals Business Companies
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Economy Novo Nordisk A/S World Markets
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Novo Nordisk A/S Labor economy Personnel
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Investing Business News U/S/ Markets
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Amgen Inc Markets NVIDIA Corp
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Goldman Sachs Group Inc Health & Science Hims & Hers Health Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Science Health care industry Eli Lilly and Co
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags World News Europe Markets Business
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Internet Enterprise Technology
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Breaking news Business Pharmaceuticals
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Science Business Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Healthy Returns Apple Inc Health care industry
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Eli Lilly and Co Viking Therapeutics Inc Health care industry
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Health care industry Eli Lilly and Co Amgen Inc
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Health care industry Eli Lilly and Co Earnings
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Novartis AG Health care industry Politics
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Policy Congress Health care industry
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Breaking news Business Pharmaceuticals
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Sweetgreen Inc Wendys Co Business
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Biotechnology US: News Companies
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Health & Science Business News Companies
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.